Chemophase FDA Approval Status
FDA Approved: No
Brand name: Chemophase
Generic name: recombinant human hyaluronidase
Company: Halozyme Therapeutics, Inc.
Treatment for: Chemoadjuvant
Chemophase is a novel recombinant investigational therapeutic being developed to enhance the delivery of chemotherapy.
Development timeline for Chemophase
| Date | Article |
|---|---|
| Jun 30, 2005 | Halozyme Therapeutics Announces Submission of Investigational New Drug Application |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
